首页 | 官方网站   微博 | 高级检索  
     

CXC趋化因子16在冠心病患者血清中的变化
引用本文:姜正明,陈魁,党瑜华,李凌,何飞,罗平,张正伟,荆素敏,张雅娉,李蕾,秦立,霍志芳.CXC趋化因子16在冠心病患者血清中的变化[J].临床荟萃,2009,24(4):284-286.
作者姓名:姜正明  陈魁  党瑜华  李凌  何飞  罗平  张正伟  荆素敏  张雅娉  李蕾  秦立  霍志芳
作者单位:郑州大学第一附属医院心内科,河南,郑州,450052
摘    要:目的探讨冠心痛患者血清中CXC趋化因子16(CXCL16)的变化。方法急性心肌梗死(AMI)组16例,不稳定型心绞痛(UAP)组26例,稳定型心绞痛(SAP)组27例,对照组19例,用酶联免疫吸附法测定患者血清中CXCLt6浓度并作比较,同时研究其与血清中肿瘤坏死因子α(TNF—α),Gensini积分之间的关系。结果与对照组相比,血清CXCL16在SAP组差异无统计学意义(P〉0.05),在UAP组和AMI组中显著升高,分剐为(2133.7±663.9)μg/LVS(2805.2±601.5)μg/L、(2827.6±677.4)μg/L(均P〈0.01);UAP组与AMI组比较差异无统计学意义(P〉0.05)。血清CXCL16与TNF-α及Gensini积分之间无线性相关(r=0.154、0.195,均P〉0.05)。与对照组相比,血清TNF-α在SAP组、UAP组和AMI组中显著升高(均P〈0.01),其中UAP组高于SAP组(P〈0.01),AMI组高于UAP组(P〈0.01)。与SAP组相比,Gensini积分在UAP组和AMI组中显著升高(P〈0.01),UAP组与AMI组间差异无统计学意义(P〉0.05)。结论血清中CXCL6水平升高可能是在急性冠状动脉综合征的发展中起重要作用。

关 键 词:冠状动脉疾病  趋化因子  CXC  肿瘤坏死因子α

Chemokine CXCL16 expression in serum of patients with coronary artery disease
JIANG Zheng-ming,CHEN Kui,DANG Yu-hua,LI Ling,HE Fei,LUO Ping,ZHANG Zheng-wei,JING Su-ming,ZHANG Ya-ping,LI Lei,QIN Li,HUO Zhi-fang.Chemokine CXCL16 expression in serum of patients with coronary artery disease[J].Clinical Focus,2009,24(4):284-286.
Authors:JIANG Zheng-ming  CHEN Kui  DANG Yu-hua  LI Ling  HE Fei  LUO Ping  ZHANG Zheng-wei  JING Su-ming  ZHANG Ya-ping  LI Lei  QIN Li  HUO Zhi-fang
Affiliation:JIANG Zheng-ming,CHEN Kui,DANG Yu-hua,LI Ling,HE Fei,LUO Ping,ZHANG Zheng-wei,JING Su-ming,ZHANG Ya-ping,LI Lei,QIN Li,HUO Zhi-fang Department of Cardiology,the First Affiliated Hospital,Zhengzhou University,Zhengzhou 450052,China
Abstract:Objective To investigate the role of soluble CXC chemokine 16 (CXCL16) in coronary atherosclerotic disease. Methods There were 69 patients with coronary artery disease(CHD) enrolled,including 16 patients with acute myocardial infarction(AMI),26 patients with unstable angina pectoris(UAP) and 27 patients with stable angina pectoris(SAP), and 19 normal controls. The expressions of CXCL16, tumor necrosis factor-alpha(TNF-α) in serum were compared using enzyme linked immunosorbent assay(ELISA), and the relationship between serumsoluble CXCL16 and Gensini score was also analyzed. Results The levels of CXCL16 in peripheral blood in UAP and AMI groups were significantly higher than those in SAP group and normal controls (P 〈0.05); however, there was no significant difference in CXCL16 expression between UAP group and AMI group ( P 〉0.05), nor did between SAP group and normal controls. And no significant correlation was found between serumsoluble CXCL16 and TNF-α or Gensini score ( r = 0. 154,0. 195 respectively, both P 〉 0.05). The serum levels of TNF-α in SAP, UAP and AMI groups were significantly higher than those in normal controls(all P 〈d0.01) ,UAP group was significantly higher than SAP group ( P 〈0.01), and AMI group was significantly higher than UAP group ( P 〈0.05). Gensini score was significantly increased in UAP and AMI groups compared to SAP group, but no significant difference was found between UAP and AMI group. Conclusion CXCL16 may play an important role in the pathogenesis and development of acute coronary syndrome.
Keywords:coronary disease  chemokines  CXC  tumor necrosis factor-alpha  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号